Sahajanand Medical Technologies Pvt. Ltd. Press releases
Jun 30, 2011
June 26, 2011. Surat, India. Sahajanand Medical Technologies (SMT) announced today that it has received European CE marking for two Sirolimus eluting coronary stent systems; Supralimus® & Supralimus-Core®
Oct 30, 2009
The 74th issue of prestigious journal CCI published an article of SMT’s PAINT Trial - A randomized evaluation of two DES with identical metallic platform and biodegradable polymer but different agents compared against Bare stents: 1-year result.
Jul 01, 2009
Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR 2009
Oct 18, 2008
"Sirolimus Eluting Stent for leading Drug Eluting Stents developer & manufacturer Sahajanand Medical Technologies displayed positive results in MAXIMUS trial that included 100 patients from the Max Heart Institute in India."
Jun 24, 2008
“For their outstanding performance, Sahajanand Medical Technologies has been awarded with Golden Jubilee Award ‘06-07 in the field of Export of Medical devices Small Scale Chemical & Pharmaceuticals."
May 14, 2008
Sahajanand Medical Technologies received positive results of nine month PAINT trials for Drug eluting stents, Infinnium and Supralimus. The results unveiled during plenary session of EuroPCR 2008-Barcelona.